Medtronic plc is a global medical technology company that develops and manufactures devices, therapies and healthcare solutions for treating chronic and acute conditions. Its products are used in areas including cardiac and vascular care, neuroscience, medical and surgical procedures, and diabetes management.
The company’s portfolio includes pacemakers, implantable cardioverter-defibrillators, cardiac ablation systems, stents and other cardiovascular products; neuromodulation systems, deep-brain stimulation devices and spinal technologies; surgical instruments, robotic-assisted surgery systems and gastrointestinal diagnostic tools; and insulin pumps and related diabetes technologies.
Medtronic traces its origins to 1949, when Earl Bakken and Palmer Hermundslie founded the company in Minneapolis, Minnesota. Bakken later developed the first battery-powered external wearable pacemaker, helping establish Medtronic as a major medical device innovator. The company serves healthcare providers and patients in markets around the world, with operations and products spanning North America, Europe, Asia-Pacific and other international regions.
Geoffrey S. Martha serves as Medtronic’s chairman and chief executive officer. The company is incorporated in Ireland and maintains significant corporate and operational activities in the United States, including in Minnesota.
AI Generated. May Contain Errors.
